Legacy Capital Group California »

Eyepoint Pharmaceuticals shares owned by Legacy Capital Group California

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Legacy Capital Group California from 13F filings

Historical chart of Legacy Capital Group California investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Legacy Capital Group California consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Legacy Capital Group California

Quarter filed Position value Share count Share price at filing
2024-03-31 $699k 34k 20.67

More positions owned by Legacy Capital Group California

Apple (AAPL)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Microsoft Corporation (MSFT)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Spdr Ser Tr Bloomberg Invt (FLRN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (FJUL)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Fs Kkr Capital Corp (FSK)
Merck & Co (MRK)
NVIDIA Corporation (NVDA)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Crowdstrike Hldgs Cl A (CRWD)
Simplify Exchange Traded Fun Enhanced Inm Etf (HIGH)

View all positions for Legacy Capital Group California

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Adage Capital Partners GP
Suvretta Capital Management
Franklin Resources
BlackRock
T. Rowe Price Associates
Vanguard Group
Millennium Management
T. Rowe Price Investment Management
Citadel Advisors
Morgan Stanley
Octagon Capital Advisors
RA Capital Management
Ikarian Capital
Goldman Sachs Group

View all funds holding Eyepoint Pharmaceuticals